InsidersTradesSigma
Track the Chimeric Therapeutics Limited share price and the full management transaction log of the company, a listed issuer based in Australia. Shares are listed on the AU market, under the oversight of ASX. Operating in the Health Care sector, Chimeric Therapeutics Limited has logged 1 public disclosures. Market capitalisation: €2.5m. The latest transaction was reported on 5 May 2026 (Change in Substantial Holding). Among the most active insiders: GKCC LLC. The full history is free.
1
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
2Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 5 May 2026
关于 Chimeric Therapeutics Limited
Chimeric Therapeutics Limited 是一家生物制药公司，专注于开发用于癌症治疗的创新细胞疗法。该公司在澳大利亚证券交易所 (ASX) 上市。